0.7803

1.59% 0.0122

Celularity Inc (CELU)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$0.7681

Offen:

$0.76

24-Stunden-Volumen:

16,276

Relative Volume:

0.12

Marktkapitalisierung:

$22.59M

Einnahmen:

$26.55M

Nettoeinkommen (Verlust:

$-91.72M

KGV:

-0.2177

EPS:

-3.584

Netto-Cashflow:

$-13.25M

1W Leistung:

+5.39%

1M Leistung:

-2.03%

6M Leistung:

-40.44%

1J Leistung:

-64.53%

1-Tages-Spanne:

$0.75

$0.8436

1-Wochen-Bereich:

$0.74

$0.8436

52-Wochen-Spanne:

$0.5601

$4.35

Celularity Inc Stock (CELU) Company Profile

Firmenname

Celularity Inc

Sektor

Healthcare (1092)

Branche

Biotechnology (603)

Telefon

(908) 768-2170

Adresse

170 PARK AVE, FLORHAM PARK

Mitarbeiter

115

Twitter

Nächster Verdiensttermin

2026-09-04

Neueste SEC-Einreichungen

CELU's Discussions on Twitter

Compare CELU vs VRTX, REGN, ARGX, RVMD, ALNY

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CELU Celularity Inc	0.7803	22.23M	26.55M	-91.72M	-13.25M	-3.584
VRTX Vertex Pharmaceuticals Inc	485.65	123.36B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	676.69	71.18B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	860.55	53.68B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	186.16	38.09B	742.00K	-1.37B	-1.07B	-7.0731
ALNY Alnylam Pharmaceuticals Inc	267.47	37.80B	4.29B	577.22M	641.34M	4.2086

Celularity Inc Stock (CELU) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-01-30	Herabstufung	Morgan Stanley	Equal-Weight → Underweight
2022-12-22	Herabstufung	Oppenheimer	Outperform → Perform
2022-06-22	Eingeleitet	H.C. Wainwright	Buy
2022-04-06	Herabstufung	Truist	Buy → Hold
2022-01-28	Eingeleitet	Oppenheimer	Outperform
2021-11-24	Eingeleitet	Morgan Stanley	Equal-Weight

Alle ansehen

Celularity Inc Aktie (CELU) Neueste Nachrichten

Jul 08, 2026

Press Release: Celularity Appoints Rick Gonzalez as Chief Commercial Officer - Moomoo

Jul 08, 2026

Jul 05, 2026

Number of shareholders of Celularity Inc. – NASDAQ:CELUW - TradingView

Jul 05, 2026

CELU Q4 2025 Earnings: Narrower-Than-Expected Loss Drives Stock HigherRevenue Growth Outlook - dars.gov.et

Jul 05, 2026

Jul 01, 2026

Celularity Inc. Warrant 2021-16.07.26 on Celularity -A- Financial Disclosures & SEC Filings - TradingView

Jul 01, 2026

Jun 30, 2026

Celularity Inc. Announces Resignation of Vincent LeVien as Director, Effective June 26, 2026 - marketscreener.com

Jun 30, 2026

Celularity Inc. Enters into a Loan Agreement with the Philip & Daniele Barach Family Trust - marketscreener.com

Jun 30, 2026

Celularity Company Profile & Introduction - Moomoo

Jun 30, 2026

Celularity Inc. Secures $1 Million Loan from Philip & Daniele Barach Family Trust – Form 8-K Filing Details and Key Agreement Terms 141519 - Minichart

Jun 30, 2026

CELULARITYSECURES $1 MLN LOAN FROM PHILIP & DANIELE BARACH FAMILY TRUSTSEC FILING - Moomoo

Jun 30, 2026

Celularity director Vincent LeVien resigns from board - TradingView

Jun 30, 2026

Insider trust lends $1M to Celularity (NASDAQ: CELU) on short term - Stock Titan

Jun 30, 2026

Jun 29, 2026

Celularity Inc (NASDAQ: CELU) Share Price, CELU Stock News, CELU Share Price & Updates - Kalkine

Jun 29, 2026

Jun 28, 2026

Enterprise value to EBIT forward of Celularity Inc. – NASDAQ:CELU - TradingView

Jun 28, 2026

Enterprise value to EBITDA forward of Celularity Inc. – NASDAQ:CELU - TradingView

Jun 28, 2026

Celularity Strengthens Leadership With New Executive Appointments - The Globe and Mail

Jun 26, 2026

Jun 25, 2026

Celularity appoints Steven N. Gordon as COO and K. Harold Fletcher as CLO & Corporate Secretary - TradingView

Jun 25, 2026

New leadership at Celularity (NASDAQ: CELU) as Gordon joins board - Stock Titan

Jun 25, 2026

Celularity Inc. Class A Actuals & Estimates (NASDAQ:CELU) - TradingView

Jun 25, 2026

Jun 24, 2026